National Cancer Institute; Notice of Meeting, 67453 [2024-18559]
Download as PDF
Federal Register / Vol. 89, No. 161 / Tuesday, August 20, 2024 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://videocast.
nih.gov/.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: September 19, 2024.
Closed: 9:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove, Seminar 110, 9609
Medical Center Drive, Rockville, MD 20850
(In Person and Virtual Meeting).
Open: 11:15 a.m. to 5:30 p.m.
Agenda: Report from the Center Director,
Special Topic Presentation, Program
Updates, Clearance of Concepts.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove, Seminar 110, 9609
Medical Center Drive, Rockville, MD 20850
In Person and Virtual Meeting.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences,
National Institutes of Health, 9609 Medical
Center Drive, Room 1E454, Rockville,
Maryland 20850, anna.ramseyewing@
nih.gov, (301) 435–0809.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at NCATSCouncilInput@
mail.nih.gov. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
ncats.nih.gov/advisory/council, where an
VerDate Sep<11>2014
17:24 Aug 19, 2024
Jkt 262001
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 14, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–18560 Filed 8–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be held as a hybrid
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: National Cancer
Institute Council of Research Advocates
(NCRA).
Date: September 18, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Director’s Update, NCI
Updates, and Legislative Update.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A,
Room 640, 35 Convent Drive, Bethesda, MD
20892 (In Person and Virtual Meeting).
Contact Person: Amy Williams, Director,
NCI Office of Advocacy Relations, National
Cancer Institute, NIH, 31 Center Drive,
Building 31, Room 10A28, Bethesda, MD
20892, (301) 496–9723, williaam@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
67453
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 14, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–18559 Filed 8–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Review of Ruth L.
Kirschstein Institutional National Research
Service Award.
Date: September 9, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, Extramural Project
E:\FR\FM\20AUN1.SGM
20AUN1
Agencies
[Federal Register Volume 89, Number 161 (Tuesday, August 20, 2024)]
[Notices]
[Page 67453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Council of Research Advocates.
The meeting will be held as a hybrid meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: National Cancer Institute Council of Research
Advocates (NCRA).
Date: September 18, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman's Remarks, NCI Director's Update,
NCI Updates, and Legislative Update.
Place: National Institutes of Health, Porter Neuroscience
Research Center, Building 35A, Room 640, 35 Convent Drive, Bethesda,
MD 20892 (In Person and Virtual Meeting).
Contact Person: Amy Williams, Director, NCI Office of Advocacy
Relations, National Cancer Institute, NIH, 31 Center Drive, Building
31, Room 10A28, Bethesda, MD 20892, (301) 496-9723,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 14, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-18559 Filed 8-19-24; 8:45 am]
BILLING CODE 4140-01-P